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Abstract 
This paper reviews the most up-to-date epidemiological evidence of the relationship 
between depression and diabetes, and considers the risk factors for the 
development of depression and the consequences of depression in diabetes with an 
emphasis on international and cross-cultural data.  The difficulties that researchers 
face when epidemiological studies require assessment of psychological phenomena, 
such as depression, across different cultural settings are explored. 
Methods: 
Relevant papers were sought on the epidemiology of diabetes and depression in 
people with diabetes by undertaking a literature search of electronic databases 
including MEDLINE, Psych-INFO, CINAHL and EMBASE. These papers were 
assessed by the authors and a narrative review of the relevant literature was 
composed.  
Results: 
Systematic reviews of the prevalence of depression in people with diabetes have 
focused on studies conducted in English speaking countries and emerging data 
suggest that there may be international variations in prevalence and also in how 
symptoms of depression are reported. There appears to be a bi-directional 
relationship between depression and diabetes, with one influencing the other; 
however, research in this area is further complicated by the fact that potential risk 
factors for depression in people with diabetes often interact with each other and with 
other factors. Further research is needed to elucidate the causal mechanisms 
underlying these associations. 
Limitations: 
Data from non-English speaking countries remain scarce and so it is difficult to come 
to any firm conclusions as to the international variation in prevalence rates of co-
morbid diabetes and depression in these countries until further research has been 
conducted. 
Conclusion: 
It is important to take a culture-centered approach to our understanding of mental 
health and illness and has outlined some of the key issues related to the 
development of culturally sensitive depression screening tools. In order to come to 
any firm conclusions about the international variation in prevalence of co-morbid 
diabetes and depression, issues of culture and diversity must be taken into account 
prior to conducting international epidemiological studies. 
Key words: epidemiology, prevalence, psychological consequences, cross-cultural 
studies, international variations. 
 
Introduction 
The close relationship between depression and diabetes has long since been 
recognised; in 1675, Willis noted that diabetes often appeared among patients who 
had experienced ‘significant life stress, sadness or long sorrow’ (Willis, 1674-1675).  
However, it was not until the late 20th century that epidemiological studies started to 
discover the complexities of the interrelationship between these two conditions.   To 
date, the majority of studies have been carried out in English speaking countries in 
the developed world, although research is now beginning to emerge from non-
English speaking counties and from low and middle income countries. In this paper 
we review the epidemiological evidence of the depression and diabetes link, the risk 
factors for the development of depression and the consequences of depression in 
diabetes with an international and cross-cultural emphasis.  Further, we explore the 
difficulties that researchers face when epidemiological studies require assessment of 
psychological phenomena such as depression across different cultural settings. 
 
Methods 
Relevant papers were sought on the epidemiology of diabetes and depression by 
undertaking a literature search of electronic databases including Academic Search 
Premier, MEDLINE, Psych-INFO, CINAHL and EMBASE. Only articles and abstracts 
published in English were considered. Based on titles and abstracts, potentially 
relevant studies were identified and the full texts of these articles were examined for 
final determination of relevance. These articles were assessed by the authors and a 
narrative review of the relevant literature was composed.  
 
International variations in prevalence of depression in diabetes 
It is now generally agreed that the prevalence of depression is increased in people 
with diabetes.  Early meta-analytic evidence showed that the overall odds of 
depression was twice as high for people with diabetes compared to non-diabetic 
controls (Odds Ratio (OR) = 2.0, 95% CI 1.8 to 2.2) (Anderson et al., 2001). This 
meta-analysis included studies of both type 1 and type 2 diabetes and no significant 
differences in prevalence were found between these two types of diabetes.  Although 
this meta-analysis is often cited to indicate that depression is highly prevalent in 
people with diabetes, the sample sizes were relatively small and only a minority of 
the studies (n= 20/48) compared prevalence data with a non-diabetes control group, 
limiting the conclusions that can be drawn.  In a more recent meta-analysis of 10 
controlled studies focussing on type 2 diabetes only, a somewhat lower prevalence 
rate of depression was found in people with diabetes compared to controls (17.6% 
vs. 9.8%; OR = 1.59; 95% CI 1.5 to 1.7) (Ali, et al., 2006).  Although no meta-
analysis has specifically looked at depression in type 1 diabetes, a systematic review 
of 4 controlled studies reported that the prevalence of clinical depression was 12.0% 
for people with type 1 diabetes compared to 3.2% in people without diabetes 
(Barnard et al., 2006).   
The studies included in these systematic reviews and meta-analyses were all 
conducted in the USA or in West-European countries.  However, rates of depression 
can vary between the sub-populations in these countries; for example, depression is 
higher in African Americans with diabetes than in their counterparts of White 
Northern European ancestry (Gary et al., 2000; Thomas et al., 2003).  Other studies 
have found even higher levels of co-morbid diabetes and depression in the US 
Latino population (Egede et al., 2003; Bell et al., 2005, Fisher et al., 2001, 2004; 
Trief, 2006) and in Native Americans (Singh et al., 2004) although a more recent 
study among Pima Indians in Arizona found no significant differences in depressive 
symptoms between those with and without diabetes (Sahota et al., 2008).  It is likely 
that differences in cultural and social dynamics along with social stressors shape the 
way illness and health are experienced in the general population.  For example, a 
study examining explanatory models of depression showed that Spanish speaking 
American Latinos experienced depression as a serious condition linked to 
acculturation and the accumulation of social stressors (Cabassa, et al., 2007).  
Physical and anxiety symptoms were commonly used to describe depression, and 
were linked to emotional distress and reduced functioning in this low-income group 
(Cabassa et al., 2008). Interestingly, the relationship between depressive symptoms 
and physical functioning was stronger in Filipino Hawaiians than in native Hawaiians 
and Hawaiians from mixed ethnic ancestry or from Japanese descent 
(Keawe’aimoku et al., 2006).  Cultural differences in the way ethnic groups express 
emotional distress may explain these differences (Ponce, 1980). Although these 
studies did not specifically focus on people with diabetes, it seems likely that these 
cultural and social dynamics also contribute to the experience of depression in that 
population.   
Recently, there has also been an increase in studies examining the prevalence of 
depression in diabetes from countries in other parts of the world.  Using a 
representative sample, a recent Brazilian study found an increased prevalence rate 
of co-morbid depression in older people (OR= 1.58; 95%CI 1.29 to 1.95) (Blay et al., 
2011). When looking at the prevalence of diabetes in people with major depressive 
disorder, a large population-based study from Taiwan found a higher prevalence of 
diabetes among individuals with diagnosed depression compared to the general 
population (OR = 1.53, 95%CI 1.39-1.69) (Chien et al.,  2011).  In this study, the 
increased prevalence of diabetes was especially prominent among people with 
depression in their thirties, suggesting that lifestyle factors among this age group 
may be involved.      
Furthermore, in a survey carried out in 60 countries across the globe, Moussavi et al. 
(2007) found that the self-reported 1-year prevalence of depressive symptoms in 
diabetes was 9.3% compared to 3.2% in people without a co-morbid condition.  The 
prevalence of depression in this study was even greater in people with arthritis 
(10.7%, 95% CI 9.1 to 12.3), angina (15.0%, 95% CI 12.9 to 17.2) and asthma 
(18.1%, 95% CI 15.9 to 20.3).   
While levels of depression were lower in a study from Pakistan, the prevalence of 
depression was nearly 15% amongst those with diabetes compared to 5% amongst 
those without diabetes (Zahid et al., 2008); this three-fold increase of depression in 
diabetes was consistent with the findings reported by Moussavi et al. (2007). High 
rates of depression have also been observed in Australia in both individuals with 
type 1 and type 2 diabetes (Hislop et al., 2008, Goldney et al., 2004), Jordan (Al-
Amer et al., 2011), Pakistan and Qatar (Bener et al., 2011).  
In summary, there is now firm evidence from studies from around the world that the 
prevalence of depression is increased in people with type 1 and type 2 diabetes; 
however, levels of depression may vary between countries and between populations 
within countries and between the sexes.   
 
Prevalence of depression in undiagnosed diabetes 
In contrast to the increased prevalence rate of depression in people with known 
diabetes, studies have found that the risk of depression is not higher in people who 
have diabetes but are unaware of having the condition.  A recent meta-analysis 
(Nouwen et al., 2011) found that the prevalence of elevated depressive symptoms in 
people with undiagnosed diabetes did not differ significantly from those with normal 
glucose metabolism (OR 0.94; 95%CI 0.71 – 1.25) but was lower than the 
prevalence among those with diagnosed diabetes (OR 0.57; 95% CI 0.45–0.74).  
Results for people with impaired glucose metabolism mirrored those of people with 
undiagnosed diabetes. Further, these results could not be attributed to differences in 
blood glucose concentration between diagnosed and undiagnosed diabetes.    In 
contrast, in a rural Bangladeshi population nearly one third (29% men, 30% women) 
of those with undiagnosed diabetes reported clinically significant levels of 
depression, compared with only 6% of men and 15% of women without diabetes 
(Asghar et al., 2007).   Since Nouwen et al’s meta-analysis, two further studies have 
reported the prevalence of depressive symptoms in undiagnosed diabetes.  In a 
study from Finland, a higher prevalence of depressive symptoms was found in 
previously diagnosed diabetes but not in undiagnosed diabetes or in those with 
impaired glucose regulation in comparison to people with normal glucose 
metabolism (Mäntyselkä et al., 2011).  In contrast, undiagnosed diabetes and 
impaired glucose tolerance was associated with a modestly increased higher 
prevalence of depressive symptoms in a large population-based study of more than 
23,000 people in southern India (Poongothai et al., 2010).  The age and gender 
adjusted ORs were 1.10 (95%CI 1.02 to 1.19) and 1.09 (95%CI 1.01 to 1.18), 
respectively, which are within the limits found in the Nouwen et al. (2011) meta-
analysis.   
Because both people with impaired glucose metabolism and undiagnosed diabetes 
have higher blood glucose concentration than people with normal glucose 
metabolism, the conclusions from these studies seem to indicate that 
hyperglycaemia per se is not associated with an increased level of depressive 
symptoms.  One explanation for this finding is that the psychological burden of 
knowing that one has diabetes, having to manage this chronic illness and to cope 
with its complications and any resulting functional impairment contributes to higher 
levels of depression.  However, this does not exclude the possibility that biological 
factors account for the difference in the prevalence of depression between 
diagnosed and undiagnosed diabetes.  For example, diabetes complications have 
been linked to the development of depression (Teodorczuk et al., 2010; Pouwer et 
al., 2003). Unfortunately differences in diabetes-related complications between 
people with undiagnosed diabetes and this with diagnosed diabetes were not taken 
into consideration in the above mentioned studies.   
It is currently unclear how and when depression develops after the diagnosis of type 
2 diabetes.  In a study from Pakistan, the prevalence of depressive symptoms in 
people with newly diagnosed diabetes was found to be significantly higher four 
weeks after diagnosis of type 2 diabetes (Perveen et al., 2010), while a large 
prospective study from the USA found that the risk of depressive disorder increased 
in the two years after diagnosis of type 2 diabetes even in the absence of diabetes 
complications (O'Connor et al., 2009).  On the other hand, a UK study found that the 
prevalence of depression was not significantly different from a normative sample in 
the first year after diagnosis, although a significant number of people had persistent 
depressive symptoms during that year (Skinner et al., 2010).  Use of antidepressant 
medication was also increased temporarily during the first year after diagnosis of 
type 2 diabetes (Kivimäki et al., 2010).  These studies indicate that during the period 
following the diagnosis of type 2 diabetes, important changes occur that are likely to 
be associated with the development of depression.  
 
Risk factors for developing depression in people with diabetes 
Although epidemiological evidence remains limited, studies have identified a number 
of risk factors that are common for both diabetes and depression, including low birth 
weight and fetal under-nutrition (Thompson et al., 2001; Paile-Hyvärinen et al., 
2007), obesity (Moreira et al, 2007) and difficulty with daily living and reduced 
autonomy (Bruce et al., 2006; Anstey et al., 2007, Pawaskar et al, 2007).  Increased 
risk for depression in people with diabetes may also be attributed to lifestyle and 
health behaviours; for example, a recent longitudinal study from the Canary Islands 
showed that intake of trans-unsaturated fatty acids, but not of mono- or 
polyunsaturated fatty acids, was associated with increased levels of depression 
(Sánchez-Villegas et al., 2011). Depression risk factors that are specific to diabetes 
include co-morbidity of diabetes-related complications (de Groot et al., 2001), and in 
particular macrovascular disease (stroke, peripheral artery disease) (Bruce et al., 
2006) and microvascular disease including retinopathy (Katon et al., 2009), 
neuropathy and nephropathy (van Steenbergen-Weijenburg et al., 2011), longer 
duration of diabetes (Padgett, 1993; Bruce et al., 2005), more demanding regimens 
(Surwit et al., 2005), low levels of daily activities (Wikblad et al., 1991; Pawaskar et 
al., 2007) and physical activity (Lysy et al., 2008), ), nutrition e.g., low intake of 
omega-3 fatty acids (Fitten et al., 2008), and perceived burden of diabetes (Polonsky 
et al, 1995).   The majority of these studies, however, were cross-sectional and 
studied factors associated with depressive symptoms rather than with a diagnosis of 
major depression.  To date, only three studies have examined longitudinal and 
multivariable risk factors for major depressive disorder.  In a sample of older adults, 
Bruce et al. (2006) found that multivariable, longitudinal predictors of depression 
(including major and minor depressive disorder) included diabetes diet, increased 
cholesterol and difficulty in daily living.   In a 5-year long longitudinal study, Katon et 
al. (2009) found that a previous history of major depressive disorder, the number of 
diabetes symptoms at baseline and having undergone cardiovascular procedures 
during the study period, significantly predicted major depressive disorder at the 5-
year follow-up.  In another study, Naranjo et al. (2011) examined demographic (age, 
gender, race, income), behavioural (diet and exercise adherence), biological (HbA1c, 
body mass index, number of co-morbidities, number of diabetes complications) and 
psychosocial factors (prior major depressive disorder, number of negative life events, 
negative affect at baseline) as possible predictors of major depressive disorder in a 
group of over 300 adults patients with type 2 diabetes during an 18-month period.  
Significant predictors of major depressive disorder were found in each of these 
categories with the exception of behaviour. However, when the significant predictors 
within these categories were entered in a combined model, only prior major 
depressive disorder and negative affect at baseline remained significant.  The results 
of these longitudinal studies therefore confirm earlier observations (e.g., Lustman et 
al., 1997; Kovacs et al., 1997b, Peyrot and Rubin, 1999) that major depressive 
disorder is a recurrent or chronic condition in diabetes.  It is important to note that 
research in this area is further complicated by the fact that potential risk factors for 
depression in people with diabetes often interact with each other and with other 
factors. For example, the relationship between duration of diabetes and depression 
may be confounded by the number of complications present.  
Consequences of depression in people with diabetes 
Although depression is a co-morbid condition in many physical health problems, 
people with diabetes who are depressed report the greatest decrements in perceived 
health compared with those with any other chronic illness (Moussavi, et al., 2007). 
For people with diabetes, the reduction in quality of life is only one of the adverse 
consequences of depression.  Depression has also been associated with 
compromised self-care (Gonzales et al.,  2008) and poor metabolic control (Lustman 
et al., 2000; Richardson et al., 2008), particularly in those taking three or more 
insulin injections per day (Surwit et al., 2005). In addition, the risk of dementia, 
already increased in people with diabetes, is further increased 2.7 fold when co-
morbid with depression (Katon et al., 2010; Katon et al., 2011). 
 
It is therefore not surprising that depression is also associated with an increased 
number of diabetes-related complications (de Groot et al., 2001), health service 
utilisation and healthcare costs (Egede et al., 2002) and mortality (Katon, 2011; 
Ismail et al., 2007).  Concerning the latter, people with diabetes and major and minor 
depression have a 2.3 and 1.67 fold increase in mortality respectively compared to 
those without depression (Katon et al., 2005). The increased mortality rates are not 
limited to people with diabetes and a clinical diagnosis of depression; significant 
depressive symptoms, as assessed by scores of ≥ 16 on the Centre for 
Epidemiologic Studies Depression Scale (CES-D) have also been  associated with 
increased mortality rates in people with diabetes by 54% compared to CES-D scores 
of < 16 (Zhang et al., 2005).  For people without diabetes, no significant relationships 
were found between depressive symptoms and mortality. 
 
Depression has been proposed to exert an additive effect in those with diabetes 
(Egede et al., 2005). A large scale study separated 10,025 participants into four 
groups according to whether they had depression or diabetes or not. During the eight 
years follow-up, mortality (by any cause) was highest in those with both depression 
and diabetes (Hazard Ratio (HR) = 2.50; 95% Confidence Interval (CI) 2.04 to 3.08), 
compared to those with neither condition. Interestingly, those with depression alone 
(HR = 1.20; 95%CI 1.03 to 1.40), or diabetes alone (HR = 1.88; 95%CI 1.55 to 2.27), 
still showed lower mortality rates than those with both conditions. This suggests 
depression and diabetes may have an adverse synergistic effect leading to the 
higher mortality rate. This effect has also been observed cross-culturally, in an older, 
Mexican American population (Black et al., 2003). 
 
While the effect of diabetes and depression upon mortality undoubtedly exists, it is 
important to disentangle the effect of depression from other behaviours and 
conditions associated with diabetes, such as diabetes self-management and 
diabetes complications. An Australian study of over 1,000 patients with type 2 
diabetes found that depression was associated with increased risk of mortality. 
Furthermore, behavioural effects secondary to depression (e.g. lower levels of 
exercise, poorer management of medications such as lipid lowering therapy) also 
contributed to the prediction of mortality. However, after adjustment for baseline 
micro- and macro-vascular complications, depression was no longer a significant 
predictor (Bruce et al., 2005) suggesting that depression increases mortality by 
increasing diabetic complications, specifically, macro-vascular and micro-vascular 
disease. However, a recent study controlling for these demographic and clinical 
characteristics, health habits and disease control measures, found major depression, 
but not minor depression, was significantly linked to all-cause mortality (HR = 1.24; 
95%CI 1.19 to 1.95), and non-cardiovascular/non-cancer mortality from causes such 
as infections and dementia (HR = 2.15; 95%CI 1.43 to 3.24), (Lin et al., 2009).  
Further research is clearly needed to elucidate the causal mechanisms underlying 
the depression and mortality association. 
 
In summary, there is now strong evidence demonstrating the relationship between 
diabetes and depression, both in terms of the prevalence and also the risk factors for 
and consequences of these co-morbid conditions for both the individual and society. 
Although the vast majority of this research has been conducted in English speaking 
countries, there is now an emerging literature from non-English speaking countries 
and from the developing world. However, this brings with it a new set of challenges 
as most depression measures have been developed outside this arena and issues of 
culture and diversity in the reporting of and experience of depression symptoms still 
require addressing. It is to these concerns that we now turn.  
 
Using depression screening tools in a global context  
The previous sections have outlined some of the key international findings with 
regard to what is known about the prevalence of co-morbid diabetes and 
depression. There is evidence that depression is under-recognised and under-
treated throughout the world, especially in primary care settings (Patel, 2001; 
Ballenger et al., 2001; Lecrubier, 2001). The World Health Organization multi-
country study demonstrated that primary care physicians in their study centres 
detected only half of all cases of depression (Sartorius et al., 1996). Treatment-
seeking for depressive symptoms is relatively rare in many non-western societies 
and among immigrant and ethnic minority groups in the west (Patel, 2001; Teja et 
al., 1971; Sue et al., 1994; Swartz et al., 1994). 
 
Most of the published research in this field has been conducted in English-speaking 
countries or in the developed world, and much less is known about the epidemiology 
of depression in people with diabetes in low or middle income countries or in non-
English speaking countries. However, an important issue that requires consideration 
is whether or not the screening tools commonly used may be simply transferrable to 
other nations or cultures of the world or whether more culturally relevant tools are 
required. 
Physician recognition of mental disorders is generally low in non-industrialised 
countries including South Asia (Patel et al., 1998), and improving recognition rates is 
a challenge because of the high patient loads, poor undergraduate training in these 
skills, and the stigma associated with mental illness and somatic presentations of 
mental disorders. There is some evidence that, even in industrialised countries such 
as the UK, general practitioners’ consultations regarding mental health problems are 
influenced by patients’ cultural beliefs and practitioners’ perception (Helman, 1999; 
Bhui et al., 2002). A number of research studies argue that the ‘Western’ 
classifications of depression proposed by both ICD–10 and DSM–IV (American 
Psychiatric Association, 1994) might not be simply applicable to other cultures 
(Bhugra and Mastrogianni, 2004; Weiss et al., 1995; Ballenger et al., 2001; 
Kirmayer, 2001). 
 
Accurate measurement of mental health illnesses is necessary not only for 
clinical and ethical reasons but also to enable comparisons between different 
cultures. Thus, defining concepts of depression in accordance with both a 
psychiatric framework and lay beliefs and taking into account social contexts and 
cultural perspectives that give meaning to everyday life should all be incorporated 
into psychiatric assessment and practice (Bhugra and Mastrogianni, 2004; Bhui, 
1999).  
 
 
Interest in culture as an important determinant in psychiatric research emerges at 
a time when there is huge demographic change in the ethnic composition of 
many Western countries. A culturally sensitive approach to healthcare is one that 
considers ethnic minorities’ particular requirements within a health system. This 
approach emphasises providing minorities with the same sort of health service as 
mainstream society, but at the same time taking into account the cultural 
‘diversities’ of the minority groups.   
 
Measuring depression across cultures has always been a source of controversy, 
but research suggests there are ethnic and cultural variations in the presentation, 
and general practitioners’ assessment and management of common mental 
health problems (Bhui and Bhugra, 2011; Hussain et al., 1997; Commander et 
al., 1997; Jacob et al., 1998). One major concern has been the use of screening 
tools that have been developed in English-speaking countries and subsequently 
utilised in non-English speaking countries (Roy et al., 2011). 
 
Different researchers and practitioners advocate different methods for measuring 
psychological well-being in people from different ethnic or cultural groups, with 
two main anthropological approaches usually considered as conflicting; the first 
of these is the ‘etic’ approach, which focuses on the perceptions of professionals 
and assumes that mental health problems can be conceptualized by a bio-
medically driven psychiatry. Hence any screening tool is considered automatically 
valid in any setting. This approach underpins the bulk of epidemiological research 
worldwide, particularly in western industrialised countries. In contrast, an ‘emic’ 
approach is one which is based on acknowledging the perceptions of the local 
community.  When it comes to the question of using depression screening 
instruments, ‘emic’ instruments are those developed in the culture in which they 
are to be used, and ’etic’ ones are developed in one culture but used without 
reservation in other cultures (Okpaku, 1998). Most research still uses ‘etic’ 
instruments, despite the criticism that one cannot apply diagnostic or other 
research instruments developed in one culture to people living in another 
(Kleinman, 1988). In order to overcome the limitations of both these approaches, 
researchers have recently attempted to combine quantitative research with an 
approach which uses local narratives and explanatory models of mental health 
problems (Aidoo and Harpham, 2001; Weiss et al., 1995; Lloyd et al., 1996). The 
use of two or more different data collection methods (often termed ‘triangulation’), 
where the findings are compared and integrated, has indeed proved useful in 
gaining insights into the research question from different perspectives.  
[Box One about here] 
 
Cultural meanings of depression 
Evidence suggests that the prevalence of depressive disorders may differ between 
countries and within countries, and across various ethnicities (Ruiz, 2001). 
Moreover, depression in individuals is known to be influenced by social and cultural 
factors, hence it is likely that the occurrence of depression will vary among and 
within societies (Miyaoka et al., 1997). In a recent empirical research study 
examining ethnic differences in depression in people with diabetes in the UK, South 
Asians reported lower levels of diagnosed depressive disorder compared with their 
white European counterparts (Ali et al., 2006). However, the authors noted that this 
may have resulted from differences in either the presentation of symptoms or a lack 
of cultural appropriateness of western methods of identifying depression. Similarly, in 
a survey of Punjabi and English general practice attendees in London, Bhui et al. 
(2001) reported that the Punjabis were not rated as having more depression than the 
English participants, but they did have more depressive ideas. Although the 
association between depression and diabetes has been found consistently, the 
trans-cultural validity of these findings remains to be shown. In our own work we 
have found that it was common for South Asians with diabetes from both the 
Bangladeshi and Pakistani communities living in the UK to express depressive 
symptomatology in somatic (physical pain) rather than cognitive terms (Lloyd et al., 
2011). During focus group sessions with Sylheti speakers in the UK and in the one-
to-one interviews with Sylheti speakers in Bangladesh, participants were asked 
whether they recognised terms such as ‘depressed’, ‘cheerful’ and ‘feeling down’, 
and were asked to consider the meaning these terms had in their culture. 
Participants were clear that they understood what feeling ‘depressed’ or ‘feeling low’ 
meant to them. However, a range of local terms and descriptions were used to 
express their understanding of the concept of depression, which are summarized in 
table 1. The participants also described a wide range of physical, emotional and 
social problems as manifestations of depression.  
 
[Table One about here] 
 
Our research findings support previous research in other cultural groups. For 
example research in Arabic populations has shown that patients use a variety of 
somatic descriptions to express the meanings of depression (Hamdi et al., 1997) and 
often associate depression with aches, pains and weakness (Sulaiman et al., 2001). 
The actual term ‘depression’ itself is often absent from the languages of many 
cultures or rarely used (Salim, 2010; Hamdi et al., 1997; Manson, 1995), or it is 
construed differently (Lloyd et al., 2011; Bhugra and Mastrogianni, 2004; Lee, 1998). 
 In those individuals with diabetes who took part in our research, depression was 
frequently described in terms of somatic symptoms, some of which may be 
confounded by the symptoms of diabetes (for example, appetite changes, poor 
concentration, fatigue). Furthermore, many of our research participants 
demonstrated a sense of the all-pervading nature of symptoms of depression which 
overlapped and impacted on how they experienced their diabetes and its 
management (Lloyd et al., 2011). This has implications for both the identification and 
the appropriate treatment of depression as well as the provision of support for 
diabetes self-management. 
 
Variations in symptoms and ways to describe depressive symptomatology can be 
seen as culturally influenced (Lloyd et al., 2011). Earlier (western) studies suggested 
that somatisation (the process by which psychological distress is ‘converted’ to 
somatic symptoms) was the cultural equivalent of depression, typically occurring in 
non-Western cultures (Patel, 2001). However, there is now growing evidence from 
studies in primary and general health care settings that somatic symptoms are 
common presenting features of depression throughout the world regardless of 
cultural background (Lloyd et al., 2011; Chowdhury, 1979; Farooq et al., 1995; Katon 
and Walker, 1998; Simon et al., 1999; Salim, 2010; Desjarlais et al., 1995). 
Reporting somatic symptoms depends on how somatisation is defined cross-
culturally (Simon et al., 1999; Lynch and Medin, 2006; Salim, 2010). Some 
symptoms may be universally recognised and some culturally distinct, but all are 
meaningful within particular cultural contexts.  Therefore, it is important to 
understand the local term(s) and the culturally distinctive understandings of the 
causes of depression, the effects of particular health problems, and help-seeking in 
the community if identification and treatment of co-morbid diabetes and depression is 
to be improved.  
 
Indeed, patients and their families may have their own ideas about the illness as 
opposed to clinicians’ views. For example, research among South Asian populations 
has shown that patients with depression usually link their depressive symptoms to 
different causes, for example any upsetting conditions, accidents or daily occurrence 
of events, unfavourable living conditions, financial problems or physical illness, and 
therefore consider it as a natural occurrence (Bhui et al., 2001;Chodhury, 1979; 
Farooq et al., 1995; Salim, 2010). In our own research, individuals with diabetes 
reported that problems with managing their diabetes led to feelings of low mood and 
hopelessness (Lloyd et al., 2011). As the meaning and understanding of the causes 
of depression change as a result of cultural and geographical influence it is crucial to 
consider these issues while developing culturally sensitive depression measurement 
instruments.   
 
Translation dilemmas in cross-cultural work in diabetes and depression 
Notwithstanding the above concerns, there remains a need to identify and offer 
treatment to those with depression or other debilitating mental illnesses, 
particularly when other physical illnesses such as diabetes co-exist. Of primary 
importance, in order to meet this aim, the concepts of depression and mental 
health and well-being need translating across cultures in order to develop 
culturally appropriate measurement tools, diagnosis and services for depression. 
At the outset, rigorous translation procedures should be in place using forward 
and backward translation techniques. In our own research these methods have 
been used, with any discrepancies in the back translation discussed and a final 
version agreed between the two translators and the researchers, a process which 
we consider as an essential step to achieve cultural accuracy and/or equivalency.  
 
In addition, the way information is collected requires consideration. Whilst 
translations may be viewed as technically accurate, and also culturally sensitive, the 
content of the questionnaires and the actual mode of data collection may still be 
seen as inappropriate by both those collecting the data as well as those providing 
the data. Self-rated instruments are not always appropriate in populations where 
there is a high prevalence of illiteracy or where the main language does not have an 
agreed written form and is only spoken (Williams et al., 1999). Our previous research 
has demonstrated the potential of a range of different modes of data collection in 
these ethnic groups, including audio versions of questionnaires, so that individuals 
may still participate in research and respond to survey tools, regardless of literacy 
level and in the knowledge that their responses are not overheard by others but are 
recorded privately and confidentially. (Lloyd et al., 2008a; Lloyd et al., 2008b; Roy 
and Lloyd, 2008).  Using alternative modes of data collection facilitates inclusivity and 
helps ensure that anyone can participate fully in both research and clinical practice.  
 
Through our own experiences in the translation and interpretation of data we have 
learned that communication across languages involves more than a literal transfer of 
information, because the participants, interpreter and researchers are all involved in 
discussing concepts, ideas, positions which are all important parts of the negotiation 
process of getting to grips with ‘cultural meaning’ and ‘cultural differences’. During 
translation and interpretation, researchers have to make decisions about the cultural 
meaning which language carries, and spend a lot of time trying to evaluate the 
degree to which different worlds inhabit the same meaning. In a similar way to a 
researcher, interpreters have to position themselves actively in the process and are 
accountable to the way they represent the informants and their culture and 
languages. Working with multilingual researchers fluent in the languages of our 
informants has been an added advantage of our studies and has helped us to more 
fully understand the complex relationship between culture and the experience of 
physical and mental health and illness. 
 
Limitations 
As data from non-English speaking countries are scarce it is difficult to obtain a clear 
picture of any international variations in the prevalence of or risk factors for co-
morbid diabetes and depression. A further challenge is the lack of information of the 
cultural applicability of depression screening tools, making between country 
comparisons problematic.  
 
Conclusions 
There is strong evidence (at least in English-speaking countries) of an increased risk 
of depression in people with diabetes as well as increased risk of developing 
diabetes in people with depression. The past two decades have seen a number of 
screening instruments being designed in developed countries, many of which have 
been adopted by international investigators for epidemiological investigations. The 
cultural applicability of these instruments, however, has yet to be established. 
 
The experience of depression is recognisable across different cultures, although 
researchers agree that clinical presentation may vary significantly and that mobility, 
migration and globalisation are likely to influence both idioms of distress and 
pathways to mental health care (Bhugra and Mastrogianni, 2004). As somatic 
symptoms are a prominent feature of depression, existing measures of depressive 
symptomatology may not be appropriate for certain language groups and it is 
important to adapt these according to cultural reality of the study settings and 
participants in order to identify those in need of psychological care and treatment.  
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BOX ONE: 
 
An ‘emic’ approach to measuring symptoms of depression: 
• Importing tools from other countries not appropriate 
• Use concepts and terms that are meaningful within a specific culture 
• Develop new tools which include culturally specific  domains 
 
An ‘etic’ approach to measuring symptoms of depression: 
• Existing tools are translated and adapted 
• Translation aims to achieve an accurate meaning rather than exact 
linguistic precision 
• Further psychometric assessment is required 
 
Table 1: Local terms for depression in Sylheti speakers in the UK and 
Bangladesh 
UK study:  
Sylheti speakers 
Bangladesh study:  
Sylheti speakers 
Bangladesh study:  
Sylheti speakers 
Duschinta (worry) 
Mon bejar (bad mood) 
Mon mora (sadness) 
Mon bala nay (not in good mood) 
Tension (anxiety) 
Dorod (paid) 
Shorir Durbol (tiredness) 
Matha var (weight on my head) 
Buk var (weight on the heart) 
Shanti nai (joylessness) 
Mental case 
Off mood  
 
Duschinta (worry) 
Chinta rog (worry illness) 
Mon bejar (bad mood) 
Mon mora (sadness) 
Mathaye tension (tension on my 
head) 
Dorod (pain) 
Matha var (weight on my head) 
Buk var (weight on my heart) 
Shanti nai (joylessness) 
Mental  
Manoshik rog (mental disorder) 
Duschinta (worry) 
Chinta rog (worry illness) 
Mon kharap (bad mood) 
Mon var (pressure on the mind) 
Tension (anxiety) 
Tension rog (anxiety illness) 
Durbolota (weakness/tiredness) 
Beytha (pain) 
Matha var (weight on the head) 
Matha nosto (going mad) 
Orthonoitik chap (financial 
tension) 
Mathaye tension (tension on the 
head) 
Buk dhorfor (palpitation) 
Buk var (weight on the chest) 
Hai hutash (grievances) 
Manoshik chap (mental 
pressure) 
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